Prenetics Global【PRE】銘柄情報

Prenetics Global Ltd (PRE) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

17.26

( -3.52% )

買値

12.69

売値

23.85

出来高

122,286

16.59 日の範囲 19.365

7.175 52 週間の範囲 23.63

時価総額

290.459M

前日終値

17.89

始値

18.04

時刻

17.5

最終取引時間

財務取引量

US$ 2,135,239

VWAP

17.461

平均取引量 (3 か月)

US$ 208,266

発行済株式数

16,828,437

配当利回り

PER

-4.82

1 株当たり利益 (EPS)

-3.33

歳入

120.07M

純利益

-50.42M

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging seque... Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.prenetics.com

本社

Quarry Bay, Hong Kong

設立

2026

Prenetics Global Ltd is listed in the Healthcare sector of the ナスダック市場 with ticker PRE. The last closing price for Prenetics Global was US$17.89. Over the last year, Prenetics Global shares have traded in a share price range of US$ 7.175 to US$ 23.63.

Prenetics Global currently has 16,828,437 shares in issue. The market capitalisation of Prenetics Global is US$290.46 million. Prenetics Global has a price to earnings ratio (PE ratio) of -4.82.

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million...

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Hudson Leogrande is the Founder and CEO of Comfrt — a multi-billion-dollar DTC brand projected to exceed $1...

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Multi-year partnership lands as Prenetics’ IM8 raises full-year 2026 revenue guidance to $190 million to $210...

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support...

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue...

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the...

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

NEW YORK and MIAMI, May 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or...

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

Partnership Extends IM8’s Mission Beyond Premium Nutrition to Address Malnutrition Among the World’s Most...

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

Giannis becomes the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, joining the...

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.IM8...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-2.61	-13.1353799698	19.87	20.43	16.96	88998	18.79788455	CS
4	-3.72	-17.7311725453	20.98	22.22	16.96	188472	20.18867934	CS
12	-1.95	-10.1509630401	19.21	22.22	14	213799	18.3902655	CS
26	1.28	8.01001251564	15.98	23.63	14	233883	18.51057161	CS
52	8.98	108.45410628	8.28	23.63	7.175	172166	16.71907394	CS
156	16.3954	1896.29886653	0.8646	23.63	0.2865	89795	12.09764638	CS
260	8.86	105.476190476	8.4	23.63	0.2865	142509	6.69439207	CS